We analyzed the relation of TRPV3 expression to the overall survival rate and found that the overall survival was significantly lower in patients with TRPV3 positive NSCLC than in patients with TRPV3 negative NSCLC (p = 0.020 Figure 2). Here, TRPV3 is linked to non-small cell lung carcinoma.